07:00 , May 28, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Ophthalmic disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Ophthalmic disease Blindness; glaucoma Latent transforming growth factor-b binding protein 2 (LTBP2) A genetic study in humans and in mice suggests...